Search
TDI-01
go.drugbank.com/drugs/DB19450InvestigationalTDI-01 is a small molecule is being developed by Beijing Tide Pharmaceutical.
Plasmin (Human)
go.drugbank.com/drugs/DB22676InvestigationalThe enzyme plasmin causes clot lysis by cleaving fibrin, a clot component.[L53453]
BO-653
go.drugbank.com/drugs/DB19216InvestigationalBO-653 is under investigation in clinical trial NCT00055510 (A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and
Green tea leaf
go.drugbank.com/drugs/DB14307InvestigationalIt is not an approved drug.
Categories: Diet, Food, and NutritionCX157
go.drugbank.com/drugs/DB05205InvestigationalCX157,3-fluoro-7-(2,2,2,-trifluoroethoxy)phenoxathiin-10,10-dioxide, is a reversible, selective inhibitor of MAO-A designed to have improved oral bioavailability and reduced clearance compared to previous
Talotrexin
go.drugbank.com/drugs/DB06178InvestigationalCategories: Amino Acids, Peptides, and ProteinsAN2898
go.drugbank.com/drugs/DB16039InvestigationalAN2898 is under investigation in clinical trial NCT01301508 (Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-moderate Atopic Dermatitis).
ADAM I-123
go.drugbank.com/drugs/DB19213InvestigationalADAM I-123 is under investigation in clinical trial NCT01160263 (Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls).
Diphencyprone
go.drugbank.com/drugs/DB12173InvestigationalDiphencyprone has been used in trials studying the treatment and basic science of Melanoma, Ultraviolet Rays, Immunosuppression, Neoplasm Metastasis, and Hypersensitivity, Delayed, among others.